Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

Muse Spark, Meta's first major new AI model in over a year, landed this week, the company's biggest effort yet to show value from its massive investment in Scale AI co-founder Alexandr Wang. Meta's ...

As usage of Anthropic’s coding-focused AI tools has surged, the company has tweaked its pricing model in a way that could make it significantly more expensive for some enterprise users. The ...

Mobile Suit Gundam: GQuuuuuuX is one of the most anticipated anime shows of the spring 2025 season, and new preorders for various figures from the series are now open on Amazon. This joint production ...

Revolution Medicines said its pancreatic cancer drug daraxonrasib succeeded in a Phase 3 trial. RevMed said its drug almost doubled the typical length of survival and slashed the risk of death by 60% ...

Good tax policy design requires evaluating fiscal regimes for extractive industries (EI) with economic and financial analysis at the project level. This website introduces key concepts and methodology ...

(Refiles to fix story link in paragraph 6, no change to text) SOFIA, April 20 (Reuters) - Pro-Russian former President Rumen Radev is set for a runaway victory in Bulgaria's election, official results ...

Here are the latest Scottish football transfer news on Monday morning involving Rangers, Celtic and a Scotland international star. These are the latest transfer rumours surrounding Scottish football ...

May 3, 2026 • Evangelicals in America are divided over immigration enforcement. So who gets to claim the side of God?